2023 BPS coverage: Diabetes, asthma, ADHD account for high drug claims in 2022
Three main drug categories — diabetes, asthma and stimulants for attention deficit hyperactivity disorder — accounted for rising drug claims in 2022, according to Lavina…
- By: Cassandra Williamson-Hopp
- July 5, 2023 June 26, 2023
- 07:56
























